{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:52:48Z","timestamp":1789944768301,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.euroneuro.2011.08.006","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T21:00:41Z","timestamp":1316120441000},"page":"281-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["The CC genotype of transforming growth factor-\u03b21 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression"],"prefix":"10.1016","volume":"22","author":[{"given":"Filippo","family":"Caraci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario S.","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena I.","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Bonforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Prestianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Panerai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Giambirtone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Salluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Copani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2011.08.006_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/187152808784165216","article-title":"Inflammatory aspects of depression","volume":"7","author":"Adler","year":"2006","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0010","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","article-title":"The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice","volume":"102","author":"Aharoni","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00001756-200404090-00025","article-title":"Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease","volume":"15","author":"Anello","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp.73.1.62","article-title":"Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease","volume":"73","author":"Araria-Goumidi","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.mad.2007.07.006","article-title":"+10 T\/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution","volume":"128","author":"Arosio","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","article-title":"Genotypic variation in the transforming growth factor-b1 gene","volume":"66","author":"Awad","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","article-title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","volume":"378","author":"Banerjee","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1469-1809.1987.tb00874.x","volume":"51","author":"Boerwinkle","year":"1987","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0045","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.neurobiolaging.2007.11.023","article-title":"Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression","volume":"30","author":"Borroni","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/156720510790691173","article-title":"Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease","volume":"7","author":"Borroni","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0055","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp.2003.025866","article-title":"Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease","volume":"75","author":"Bosco","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0060","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/jnnp.57.12.1510","article-title":"A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment","volume":"57","author":"Brazzelli","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0065","first-page":"455","article-title":"Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders","volume":"13","author":"Cacabelos","year":"1991","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nbd.2008.01.007","article-title":"TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway","volume":"30","author":"Caraci","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0075","article-title":"TGF-beta1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease","author":"Caraci","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer's disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0085","author":"Caraci","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2006.06.019","article-title":"Neurotrophins and dementia-keeping in touch","volume":"51","author":"Castren","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/156720508784533321","article-title":"Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses","volume":"5","author":"Cerpa","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11064-005-6960-y","article-title":"The role of neurotrophins in brain aging: a perspective in honor of Regino Perez-Polo","volume":"30","author":"Cotman","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/039463201002300204","article-title":"The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature","volume":"23","author":"De Berardis","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0115","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/j.1460-9568.2006.04780.x","article-title":"Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia","volume":"23","author":"Di Rosa","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.b.30218","article-title":"Association studies of transforming growth factor-beta 1 and Alzheimer's disease","volume":"139B","author":"Dickson","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1212\/WNL.0b013e3181e62124","article-title":"Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment","volume":"75","author":"Dotson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/15622971003797241","article-title":"Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment","volume":"11","author":"Forlenza","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/8.1.93","article-title":"Genetic control of the circulating concentration of transforming growth factor type beta1","volume":"8","author":"Grainger","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2008.05.008","article-title":"Genetic risk factors and markers for Alzheimer's disease and\/or depression in the VITA study","volume":"43","author":"Gr\u00fcnblatt","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0150","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jnnp.2003.034454","article-title":"Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy","volume":"76","author":"Hamaguchi","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixon","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12603-010-0325-1","article-title":"Transforming growth factor Beta and soluble endoglin in the healthy senior and in Alzheimer 's disease patients","volume":"14","author":"Juraskova","year":"2010","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/jnnp.2003.031773","article-title":"Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?","volume":"275","author":"Kessing","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2008.11.020","article-title":"Antidepressants and dementia","volume":"117","author":"Kessing","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.gde.2011.02.002","article-title":"Genetics of Alzheimer's disease: new evidences for an old hypothesis?","volume":"21","author":"Lambert","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0205","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0210","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.intimp.2006.03.015","article-title":"The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive Disorder","volume":"6","author":"Lee","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0215","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","article-title":"Inflammation, depression and dementia: are they connected?","volume":"32","author":"Leonard","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s004390000313","article-title":"Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease","volume":"106","author":"Luedecking","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.archger.2009.09.027","article-title":"Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS)","volume":"49","author":"Luppi","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0230","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archneur.57.8.1153","article-title":"Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia","volume":"57","author":"Luterman","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0235","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/jnp.9.4.556","article-title":"Major and minor depression in Alzheimer's disease: prevalence and impact","volume":"9","author":"Lyketsos","year":"1997","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0245","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0250","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.exger.2004.07.007","article-title":"Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1,as possible differential markers of Alzheimer disease","volume":"39","author":"Mocali","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0255","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2007.09.002","article-title":"Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression","volume":"114","author":"Motta","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","article-title":"Th1, Th2, and Th3 cytokine alterations in major depression","volume":"88","author":"Myint","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1176\/jnp.14.3.329","article-title":"Disease-specific properties of the Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease","volume":"14","author":"Naarding","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000338622.27876.0d","article-title":"Microglial activation and amyloid deposition in mild cognitive impairment: a PET study","volume":"72","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0285","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0390","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0290","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.neurobiolaging.2006.06.004","article-title":"A TGF-beta1 polymorphism association with dementia and neuropathologies: the HAAS","volume":"28","author":"Peila","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0966-3274(99)80030-6","article-title":"ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta1 gene polymorphisms","volume":"7","author":"Perrey","year":"1999","journal-title":"Transplant. Immunol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0300","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cytogfr.2007.04.005","article-title":"TGF-beta1: a novel target for cardiovascular pharmacology","volume":"18","author":"Redondo","year":"2007","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0305","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10072-010-0221-9","article-title":"Cytokine polymorphisms and Alzheimer disease: possible associations","volume":"31","author":"Ribizzi","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0310","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1600-0404.2007.00892.x","article-title":"Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease","volume":"116","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease","volume":"39","author":"Rojo","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0320","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.archger.2005.11.002","article-title":"Depression as prognostic factor: 6months follow-up in a geriatric institution","volume":"43","author":"Shim","year":"2006","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0325","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3956(97)00023-X","article-title":"Circulating cytokines in Alzheimer's disease","volume":"31","author":"Singh","year":"1997","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jnr.1229","article-title":"Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex","volume":"66","author":"Sometani","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0335","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1176\/appi.ajp.162.11.2086","article-title":"The construct of minor and major depression in Alzheimer's disease","volume":"162","author":"Starkstein","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0340","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0345","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2006.03.050","article-title":"Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study","volume":"402","author":"Van Oijen","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2005.09.011","article-title":"Transforming growth factor-\u03b2 signalling in brain disorder","volume":"17","author":"Vivien","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0360","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0365","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002093-199903000-00007","article-title":"History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample","volume":"13","author":"Wetherell","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0370","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0375","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pneurobio.2010.04.005","article-title":"The putative neurodegenerative links between depression and Alzheimer's disease","volume":"91","author":"Wuwongse","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720506777632916","article-title":"Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's","volume":"3","author":"Wyss-Coray","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.euroneuro.2011.08.006_bb0385","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/01.CIR.101.24.2783","article-title":"Association of a T29->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese","volume":"101","author":"Yokota","year":"2000","journal-title":"Circulation"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:50:08Z","timestamp":1760377808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X11002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0924977X11002057"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2011.08.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CC genotype of transforming growth factor-\u03b21 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2011.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}